Dynamic Technology Lab Private Ltd Invests $940,000 in The Chemours Company (NYSE:CC)

Dynamic Technology Lab Private Ltd bought a new position in The Chemours Company (NYSE:CC - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 55,643 shares of the specialty chemicals company's stock, valued at approximately $940,000.

A number of other large investors have also recently made changes to their positions in the business. GAMMA Investing LLC grew its position in Chemours by 99.7% in the 4th quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company's stock worth $26,000 after purchasing an additional 765 shares in the last quarter. KBC Group NV lifted its position in shares of Chemours by 38.2% during the fourth quarter. KBC Group NV now owns 6,176 shares of the specialty chemicals company's stock worth $104,000 after acquiring an additional 1,708 shares in the last quarter. EMC Capital Management boosted its holdings in shares of Chemours by 74.6% in the fourth quarter. EMC Capital Management now owns 9,534 shares of the specialty chemicals company's stock worth $161,000 after acquiring an additional 4,073 shares during the period. Matrix Trust Co grew its position in shares of Chemours by 715.7% in the fourth quarter. Matrix Trust Co now owns 9,952 shares of the specialty chemicals company's stock valued at $168,000 after purchasing an additional 8,732 shares in the last quarter. Finally, Larson Financial Group LLC purchased a new stake in Chemours during the 4th quarter worth about $205,000. 76.26% of the stock is owned by institutional investors.

Analysts Set New Price Targets

CC has been the subject of a number of recent analyst reports. Royal Bank of Canada reaffirmed an "outperform" rating and set a $25.00 target price on shares of Chemours in a report on Thursday, December 12th. BMO Capital Markets reduced their price objective on shares of Chemours from $34.00 to $27.00 and set an "outperform" rating for the company in a research note on Wednesday, February 19th. Barclays lowered their target price on shares of Chemours from $19.00 to $16.00 and set an "equal weight" rating on the stock in a research note on Tuesday, April 1st. The Goldman Sachs Group reduced their price target on shares of Chemours from $24.00 to $21.00 and set a "neutral" rating for the company in a research report on Tuesday, January 7th. Finally, Mizuho raised shares of Chemours from a "neutral" rating to an "outperform" rating and set a $19.00 price target on the stock in a report on Thursday, March 27th. Four analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $22.56.

Remove Ads

Chemours Price Performance

Shares of NYSE CC traded down $0.10 during trading hours on Friday, reaching $10.71. 605,397 shares of the stock traded hands, compared to its average volume of 1,807,077. The company's 50-day simple moving average is $14.69 and its two-hundred day simple moving average is $17.67. The company has a market capitalization of $1.60 billion, a P/E ratio of 18.80 and a beta of 1.84. The Chemours Company has a 52-week low of $9.33 and a 52-week high of $29.21. The company has a quick ratio of 0.92, a current ratio of 1.68 and a debt-to-equity ratio of 6.70.

Chemours (NYSE:CC - Get Free Report) last announced its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.10 by $0.01. The company had revenue of $1.36 billion during the quarter, compared to analysts' expectations of $1.37 billion. Chemours had a net margin of 1.51% and a return on equity of 26.54%. Equities research analysts forecast that The Chemours Company will post 2.03 EPS for the current year.

Chemours Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were issued a $0.25 dividend. The ex-dividend date of this dividend was Friday, February 28th. This represents a $1.00 annualized dividend and a dividend yield of 9.34%. Chemours's dividend payout ratio is currently 175.44%.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.